|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.89 CNY | +1.59% |
|
+3.11% | +2.24% |
| Capitalization | 2.42TCr 348.11Cr 296.69Cr 274.9Cr 258.54Cr 481.23Cr 32TCr 516.21Cr 3.17TCr 1.25TCr 15TCr 1.31TCr 1.28TCr 55TCr | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 1.32TCr 190.18Cr 162.09Cr 150.18Cr 141.24Cr 262.91Cr 17TCr 282.01Cr 1.73TCr 684.86Cr 8.23TCr 713.16Cr 698.54Cr 30TCr | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
37.52% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | +1.59% | ||
| 1 week | +3.11% | ||
| Current month | +2.24% | ||
| 1 month | +1.17% | ||
| 3 months | +6.66% | ||
| 6 months | -2.57% | ||
| Current year | +2.24% |
| 1 week | 25.99 |  | 26.99 |
| 1 month | 25.83 | | 27.03 |
| Current year | 25.83 | | 26.99 |
| 1 year | 24.2 | | 30.39 |
| 3 years | 23.85 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 20/12/2019 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 26/09/2022 |
Wei Cao
SEC | Corporate Secretary | 40 | 17/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Long Xiang Cao
CHM | Chairman | 69 | 10/03/2014 |
Qu Rong Huang
BRD | Director/Board Member | 64 | 10/03/2014 |
Fei Cao
BRD | Director/Board Member | 43 | 10/03/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.59% | +3.11% | -3.96% | -8.23% | 350.23Cr | |
| +0.22% | -3.27% | -15.50% | -33.27% | 616.07Cr | |
| +1.65% | +0.69% | -17.98% | +13.19% | 452.46Cr | |
| +0.35% | -1.55% | +50.41% | +43.76% | 438.75Cr | |
| +2.03% | +1.97% | +15.40% | -37.27% | 426.35Cr | |
| +0.26% | -1.43% | +4.78% | +30.18% | 323.96Cr | |
| +0.77% | +1.50% | +9.63% | -20.11% | 254.88Cr | |
| -0.61% | -2.10% | +14.10% | +1.97% | 199.78Cr | |
| +1.39% | +0.05% | -2.44% | +52.08% | 168.87Cr | |
| +3.18% | +3.49% | +14.83% | +53.11% | 168.84Cr | |
| Average | +1.08% | +1.01% | +6.93% | +9.54% | 340.02Cr | |
| Weighted average by Cap. | +1.00% | +0.82% | +5.45% | +2.56% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 154.7Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.02TCr 33Cr 202.61Cr 80Cr 961.92Cr 83Cr 82Cr 3.51TCr | 172.4Cr 25Cr 21Cr 20Cr 18Cr 34Cr 2.25TCr 37Cr 225.79Cr 89Cr 1.07TCr 93Cr 91Cr 3.91TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,026
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 26.89 ¥ | +1.59% | 47,32,034 |
| 19/26/19 | 26.47 ¥ | +0.72% | 41,48,719 |
| 16/26/16 | 26.28 ¥ | -0.90% | 41,54,227 |
| 15/26/15 | 26.52 ¥ | +1.57% | 59,01,602 |
| 14/26/14 | 26.11 ¥ | +0.12% | 50,40,241 |
End-of-day quote Shanghai S.E., January 20, 2026
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.89
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600566 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition